Darbotin 25 Injection
Marketer
Wockhardt Ltd
Salt Composition
Darbepoetin alfa (25mcg)
Overview Darbotin 25 Injection
Erythropoietin alfa (Darbotin 25 Injection) treats anemia stemming from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. Administered under medical supervision, this medication demands careful use due to potential serious adverse reactions. Expert medical guidance is essential; adhere strictly to your physician's instructions. Common side effects may include abdominal discomfort, hypertension, skin rash, injection site soreness, dyspnea, cough, and peripheral swelling. Report symptoms of severe hypertension, such as intense headache, visual disturbances, nausea, vomiting, or convulsions, immediately. Regular blood tests, monitoring electrolytes (like potassium), hemoglobin, and blood cell counts, are typically conducted. Discontinue use and seek medical attention for sudden shortness of breath or skin eruptions. Prior to treatment, inform your doctor of any pre-existing heart conditions, hypertension, seizure history, or stroke. Consult your doctor regarding the safety of this injection during pregnancy, breastfeeding, or pregnancy planning.
Uses of Darbotin 25 Injection
Managing anemia associated with chronic kidney failure | Addressing anemia resulting from cancer treatments
Major Benefits of Darbotin 25 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Darbotin 25 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Darbotin 25 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Darbotin 25 Injection works:
Darbotin 25 Injection is an erythropoietin-based medication that boosts red blood cell production. It achieves this by stimulating the bone marrow, the blood cell-forming tissue within bones, to increase its output of red blood cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Darbotin 25 Injection may be unsafe; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Darbotin 25 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Darbotin 25 Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Darbotin 25 Injection.
KidneySAFE IF PRESCRIBED
Darbotin 25 Injection poses no safety concerns for individuals with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Individuals with hepatic impairment should use Darbotin 25 Injection cautiously. Dosage modification for Darbotin 25 Injection might be necessary. Physician consultation is advised.
What if you forget to take Darbotin 25 Injection :
Should you forget a Darbotin 25 Injection dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Darbotin 25 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |
3,018 People bought this recently